AU2899900A - Cloned human sphingosine kinase homologues - Google Patents

Cloned human sphingosine kinase homologues

Info

Publication number
AU2899900A
AU2899900A AU28999/00A AU2899900A AU2899900A AU 2899900 A AU2899900 A AU 2899900A AU 28999/00 A AU28999/00 A AU 28999/00A AU 2899900 A AU2899900 A AU 2899900A AU 2899900 A AU2899900 A AU 2899900A
Authority
AU
Australia
Prior art keywords
sphingosine kinase
cloned human
human sphingosine
kinase homologues
homologues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28999/00A
Inventor
Germaine R. Falzone
Ashwani Gupta
Donald Munroe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NPS Allelix Corp Canada
Original Assignee
NPS Allelix Corp Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NPS Allelix Corp Canada filed Critical NPS Allelix Corp Canada
Publication of AU2899900A publication Critical patent/AU2899900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
AU28999/00A 1999-03-02 2000-03-02 Cloned human sphingosine kinase homologues Abandoned AU2899900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12251699P 1999-03-02 1999-03-02
US60122516 1999-03-02
PCT/CA2000/000223 WO2000052173A2 (en) 1999-03-02 2000-03-02 Cloned human sphingosine kinase homologues

Publications (1)

Publication Number Publication Date
AU2899900A true AU2899900A (en) 2000-09-21

Family

ID=22403154

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28999/00A Abandoned AU2899900A (en) 1999-03-02 2000-03-02 Cloned human sphingosine kinase homologues

Country Status (2)

Country Link
AU (1) AU2899900A (en)
WO (1) WO2000052173A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001262734B2 (en) * 2000-06-14 2004-09-30 Sankyo Company, Limited Ceramide kinase and DNA encoding the same

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60027295T2 (en) 1999-05-13 2007-01-18 Johnson & Johnson Pharmaceutical Research & Development, Llc SPHINGOSINEKINASE
MXPA02004294A (en) * 1999-10-28 2002-10-31 Warner Lambert Co Human sphingosine kinase gene.
WO2001060990A2 (en) * 2000-02-14 2001-08-23 Curagen Corporation Sphingosine kinases
DE60140605D1 (en) * 2000-04-03 2010-01-07 Daiichi Sankyo Co Ltd ISOFORMS OF TYPE 2 SPHINGOSINKINASE OF MAMMALS, CLONING, EXPRESSION AND METHOD OF USE
US7037700B2 (en) 2000-10-06 2006-05-02 Bayer Aktiengesellschaft Regulation of human ceramide kinase
US20030125533A1 (en) * 2000-10-06 2003-07-03 Sophia Kossida Regulation of human sphingosine kinase-like protein
CA2432978C (en) 2000-12-22 2012-08-28 Medlyte, Inc. Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
DE10064899A1 (en) 2000-12-23 2002-07-25 Bosch Gmbh Robert Device for driving an output member
WO2003031628A1 (en) * 2001-09-28 2003-04-17 Hokkaido Technology Licensing Office Co., Ltd. Secretory polypeptides having sphingosine kinase activity and sphingosine kinase genes encoding the same
WO2003031627A1 (en) * 2001-09-28 2003-04-17 Hokkaido Technology Licensing Office Co., Ltd. Platelet-origin polypeptides having sphingosine kinase activity and sphingosine kinase genes encoding the same
US20080138334A1 (en) 2006-05-31 2008-06-12 Sabbadini Roger A Immune-Derived Moieties Reactive Against Bioactive Lipids, and Methods of Making and Using Same
US9274129B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Methods and reagents for detecting bioactive lipids
US9274130B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Prevention and treatment of pain using antibodies to lysophosphatidic acid
JP5795833B2 (en) 2006-10-27 2015-10-14 エルパス・インコーポレイテッドＬｐａｔｈ， Ｉｎｃ． Compositions and methods for binding sphingosine-1-phosphate
US8871202B2 (en) 2008-10-24 2014-10-28 Lpath, Inc. Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
WO2019182191A1 (en) * 2018-03-21 2019-09-26 경북대학교 산학협력단 Pharmaceutical composition for prevention or treatment of neurodegenerative disease and comprising cox2-acetylating agent as active ingredient

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001262734B2 (en) * 2000-06-14 2004-09-30 Sankyo Company, Limited Ceramide kinase and DNA encoding the same

Also Published As

Publication number Publication date
WO2000052173A2 (en) 2000-09-08
WO2000052173A3 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
AU3286299A (en) Lowering skin temperature
PL342668A1 (en) Antibodies against human cd40
AU1315900A (en) Protein kinase homologs
AU2899900A (en) Cloned human sphingosine kinase homologues
AU1101699A (en) Therapeutic pillow
AU141983S (en) Chair
AU2187301A (en) Protein kinase regulation
AU1020201A (en) Human sphingosine kinase gene
AU1557901A (en) Chair
AU141984S (en) Chair
AU1548101A (en) Sphingosine derivatives
AU5211299A (en) Human checkpoint kinase
AU2591299A (en) Human protein kinase c inhibitor
AU4456800A (en) Human hac3
AU2223599A (en) Human growth factor homologs
AU1526501A (en) Chair
AU2001271244A1 (en) Novel human uridine kinase
AU2411401A (en) Mattress
CA86689S (en) Chair
CA86702S (en) Chair
CA86691S (en) Chair
CA86704S (en) Chair
CA86703S (en) Chair
CA86690S (en) Chair
CA88177S (en) Chair

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase